These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32631014)

  • 1. [Early effects of attendance to the Friuli Venezia Giulia (Northern Italy) mammography screening programme on the incidence of advanced-stage breast cancer: a cohort study].
    Giudici F; Bortul M; Clagnan E; Del Zotto S; Franzo A; Giordano L; Gobbato M; Puliti D; Serraino D; Zucchetto A; Zanier L; Zanconati F; Bucchi L
    Epidemiol Prev; 2020; 44(2-3):145-153. PubMed ID: 32631014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy.
    Puliti D; Bucchi L; Mancini S; Paci E; Baracco S; Campari C; Canuti D; Cirilli C; Collina N; Conti GM; Di Felice E; Falcini F; Michiara M; Negri R; Ravaioli A; Sassoli De' Bianchi P; Serafini M; Zorzi M; Caldarella A; Cataliotti L; Zappa M;
    Eur J Cancer; 2017 Apr; 75():109-116. PubMed ID: 28222306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.
    Foca F; Mancini S; Bucchi L; Puliti D; Zappa M; Naldoni C; Falcini F; Gambino ML; Piffer S; Sanoja Gonzalez ME; Stracci F; Zorzi M; Paci E;
    Cancer; 2013 Jun; 119(11):2022-8. PubMed ID: 23504860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].
    Castriotta L; Rosolen V; Barbiero F; Tomietto M; de Dottori M; Barbone F; Zamaro G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):128-135. PubMed ID: 33412803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study.
    Puliti D; Zappa M; Giorgi Rossi P; Pierpaoli E; Manneschi G; Ambrogetti D; Ventura L; Mantellini P;
    Breast Cancer Res; 2018 Aug; 20(1):95. PubMed ID: 30092817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria.
    Oberaigner W; Geiger-Gritsch S; Edlinger M; Daniaux M; Knapp R; Hubalek M; Siebert U; Marth C; Buchberger W
    Breast; 2017 Jun; 33():178-182. PubMed ID: 28419909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma.
    Zackrisson S; Andersson I; Manjer J; Janzon L
    Int J Cancer; 2004 Feb; 108(5):754-60. PubMed ID: 14696103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
    de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
    Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 infections in the Friuli Venezia Giulia Region (Northern Italy): a population-based retrospective analysis.
    Calagnan E; Gobbato M; Burba I; Del Zotto S; Toffolutti F; Serraino D; Tonutti G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):323-329. PubMed ID: 33412825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of non-attendance for second round mammography in an Australian mammographic screening programme.
    O'Byrne AM; Kavanagh AM; Ugoni A; Diver F
    J Med Screen; 2000; 7(4):190-4. PubMed ID: 11202585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing harms and benefits of service mammography screening programs: a cohort study.
    Puliti D; Miccinesi G; Zappa M; Manneschi G; Crocetti E; Paci E
    Breast Cancer Res; 2012 Jan; 14(1):R9. PubMed ID: 22230345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
    Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
    Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, detection, and tumour stage of breast cancer in a cohort of Italian women with negative screening mammography report recommending early (short-interval) rescreen.
    Ravaioli A; Foca F; Colamartini A; Falcini F; Naldoni C; Finarelli AC; de Bianchi PS; Bucchi L
    BMC Med; 2010 Feb; 8():11. PubMed ID: 20122145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of mammographic screening and advanced cancer definition on the percentage of advanced-stage cancers in a steady-state breast screening programme in the Netherlands.
    de Munck L; Siesling S; Fracheboud J; den Heeten GJ; Broeders MJM; de Bock GH
    Br J Cancer; 2020 Sep; 123(7):1191-1197. PubMed ID: 32641863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with non-participation of women in a breast cancer screening programme in a town in northern Italy.
    Donato F; Bollani A; Spiazzi R; Soldo M; Pasquale L; Monarca S; Lucini L; Nardi G
    J Epidemiol Community Health; 1991 Mar; 45(1):59-64. PubMed ID: 2045747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attending the breast screening programme after breast cancer treatment: a population-based study.
    de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
    Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.